Human Biospecimens in the Era of Personalized Medicine March 16, 2011

Modern biomedical research requires continuous supply of legally and ethically acquired high quality human biospecimens and associated data. Preservation of pre-analytical biospecimen variables, significantly confounding research of the disease biomarkers and development of modern diagnostics, will be discussed. Other topics include: collection of biospecimens using standard protocols versus custom protocols; effective use of currently available biorepositories for future studies on the indicated subject; relevant regulatory and legal issues, including international disparities in regulations on use of human materials for biomedical research.

* Human biospecimens: the foundation of translational medical research
* Important pre-analytical aspects of human biospecimen procurement:
o tissue collection specifications
o processing materials and methods
o storage and shipping procedures
o analyte preparation techniques
* Standard operating procedures:
o collection and handling of human biospecimens
o legal and ethical considerations
o clinical data collection and management
* Project-based collection protocols and custom assay development
* Effective utilization of human biospecimens in modern biomedical research, including development of new drugs, novel biomarkers and personalized molecular diagnostics

SPEAKER
Olga Potapova, Ph.D., Founder, CEO and Scientific Director, Cureline, Inc.

Official Website: http://personalizedmedicine.eventbrite.com/